Navigation Links
Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
Date:5/15/2009

Completion of enrollment keeps Company on track to report primary study results in third quarter of this year

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that enrollment has been completed in the second Phase II clinical trial of its trivalent virus-like particle (VLP) seasonal influenza vaccine. This Phase IIa randomized, placebo-controlled study is evaluating a VLP vaccine against the H3N2, H1N1, and B influenza strains that circulated in the 2008-2009 influenza season. This clinical trial represents another step in the development of Novavax's VLP seasonal influenza vaccine, allowing further evaluation of safety and immunogenicity of a broad range of vaccine doses against a new set of influenza strains. As announced in December of 2008, the first Phase II study evaluated a trivalent VLP vaccine against the seasonal influenza strains that circulated in the 2005-2006 influenza season.

Specifically, this new study is evaluating the safety and immunogenicity of the 2008-2009 influenza vaccine in approximately 220 healthy adults between the ages of 18 and 49 years. Subjects have received a single injection of either a placebo or the VLP vaccine at doses of 15 mcg or 60 mcg per strain. The results of this study will be used to help select a dose for further evaluation in a clinical trial involving adults 65 years of age and older later this year and in a subsequent Phase III efficacy study.

"Enrollment of this second Phase II clinical trial represents another important developmental milestone for our VLP seasonal influenza vaccine program," said Dr. Rahul Singhvi, President and CEO of Novavax. "This study provides the opportunity to evaluate the safety and immunogenicity of our VLP vaccine against a new set of influenza strains, further strengthening our growing
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Mass. , May 20, 2013 ... and advisory firms for pharmaceutical and healthcare issues, ... that therapies offering a greater effect on quality ... unmet need. Given the high level of subjectivity ... of life, interviewed thought leaders state that it ...
(Date:5/19/2013)... 2013  The non-surgical Stretta® procedure ... energy is effective in control of gastroesophageal reflux ... for medication 10 years post-procedure, according to an ... Digestive Disease Week (DDW) meeting May 18-21, 2013 ... "The sustained improvement in GERD-HRQL scores ...
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
Breaking Medicine Technology:For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
(Date:5/20/2013)... 6Webs.com is the leading supplier of unbiased ... recently completed their assessments of the top alarm system ... and the top home security system companies are ranked ... equipment and warranties to mention a few. , ... completed the home security reviews, numerous people claimed that ...
(Date:5/20/2013)... Selexis SA, a serial innovation company ... line development for scale-up and manufacturing of therapeutic protein ... data on the Company’s core technology at the 2013 ... 20 - 23 at the Hyatt Regency La Jolla ... scientific advisory board member, Nicolas Mermod, PhD, Professor of ...
(Date:5/20/2013)... A new Canadian study has uncovered an apparent gender ... than men to get trauma center care following a ... care services in general have been recognized for some ... to the treatment of severe injuries in trauma centers," ... Health Sciences Centre and the University of Toronto, said ...
(Date:5/20/2013)... Texas (PRWEB) May 20, 2013 ... Phytel, the leader in automated, provider-led population health ... systems to effect change and successfully pursue population ... advisory services and technology to accelerate the transition ... the VHA IMPERATIVTM performance improvement suite of services, ...
(Date:5/20/2013)... between use of anabolic-androgenic steroids and reduced mental health ... a new study on elite male strength athletes that ... the British Journal of Sports Medicine . Twenty ... steroid use. , The study is published by ... education and research on addiction. Together with colleagues from ...
Breaking Medicine News(10 mins):Health News:Best Home Alarm System Companies in 2013 Published by Leading Security Reviews Site - 6Webs.com 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 2Health News:Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering 3Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4
... Ambo ... Year category for the 2010 Frank G. Berlin, Sr. Small Business of the Year Awards presented ... contains as much omega-3 fish oil as a filet of salmon. , ... Venice, FL (PRWEB) April 27, 2010 -- Ambo Foods, LLC, maker ...
... needed, researchers suggest , TUESDAY, April 27 (HealthDay News) -- ... chronic kidney disease have more severe anemia than white patients, ... low levels of red blood cells, is diagnosed by measuring ... out of red blood cells. In general, hemoglobin levels below ...
... ... baby blankets brings personalization to the one gift event where personalization has been impossible. ,Ensure ... as it is memorable. , ... (PRWEB) April 27, 2010 -- Fill In The Blankie provides the solution to presenting a ...
... disease, researchers at Mount Sinai School of Medicine have found ... brain, rather than the amyloid plaques previously thought by many ... which was supported by the "Oligomer Research Consortium" of the ... Administration, appears in the journal Annals of Neurology . ...
... , ... Latest Free, Easy to Use, Yet Extremely Powerful Tool Designed for System Administrators and Application ... ... VKernel , the award winning provider of capacity management products for virtualized datacenters announced ...
... ... allergy elimination as opposed to allergy prevention. Absolute Health is a unique healthcare facility ... symptoms caused by allergies that actually quell allergies as opposed to simply preventing them. ... Scottsdale, AZ ...
Cached Medicine News:Health News:Omega-3 Cookie Company Recognized as Finalist for Prestigious Business Award 2Health News:Anemia Harder to Treat in Black Children With Kidney Disease 2Health News:Myth Debunked: Baby Shower Gifts CAN Be Personalized Without Knowing Name Or Gender 2Health News:Myth Debunked: Baby Shower Gifts CAN Be Personalized Without Knowing Name Or Gender 3Health News:Alzheimer's memory problems originate with protein clumps floating in the brain, not amyloid plaques 2Health News:New VKernel AppVIEW 1.0 for Monitoring and Identification of Capacity Bottlenecks in Critical Application VMs 2Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 2Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 3
Provides secure fracture immobilization while allowing for full range of motion at elbow and wrist...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint ... align the hand with ulnar deviation at ... impede grasp or pinch. Radial and ulnar ... ensure unimpeded flexion and extension. Padded, malleable ...
... Orthosis For quick, efficient immobilization of ... immobilizes and protects the fracture and ... comfort, support, and conformity to the ... shell may be gently heated (with ...
Medicine Products: